{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:14:50Z","timestamp":1787008490205,"version":"build-2736575974"},"reference-count":150,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Louis and Elsa Thomsen Distinguished Graduate"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HD094759"],"award-info":[{"award-number":["R01HD094759"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Maternal use of antidepressants has increased throughout the last decades; selective serotonin reuptake inhibitors (SSRI) are the most prescribed antidepressants. Despite the widespread use of SSRI by women during reproductive age and pregnant women, an increasing amount of research warns of possible detrimental effects of maternal use of SSRI during pregnancy including low birthweight\/small for gestational age and preterm birth. In this review, we revisited the impact of maternal use of SSRI during pregnancy, its impact on serotonin homeostasis in the maternal and fetal circulation and the placenta, and its impact on pregnancy outcomes\u2014particularly intrauterine growth restriction and preterm birth. Maternal use of SSRI increases maternal and fetal serotonin. The increase in maternal circulating serotonin and serotonin signaling likely promotes vasoconstriction of the uterine and placental vascular beds decreasing blood perfusion to the uterus and consequently to the placenta and fetus with potential impact on placental function and fetal development. Several adverse pregnancy outcomes are similar between women, sheep, and rodents (decreased placental size, decreased birthweight, shorter gestation length\/preterm birth, neonatal morbidity, and mortality) highlighting the importance of animal studies to assess the impacts of SSRI. Herein, we address the complex interactions between maternal SSRI use during gestation, circulating serotonin, and the regulation of blood perfusion to the uterus and fetoplacental unit, fetal growth, and pregnancy complications.<\/jats:p>","DOI":"10.1093\/biolre\/ioad046","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T14:37:08Z","timestamp":1682433428000},"page":"17-28","source":"Crossref","is-referenced-by-count":22,"title":["Maternal serotonin: implications for the use of selective serotonin reuptake inhibitors during gestation"],"prefix":"10.1093","volume":"109","author":[{"given":"Rafael R","family":"Domingues","sequence":"first","affiliation":[{"name":"Department of Animal and Dairy Sciences, University of Wisconsin-Madison , Madison, Wisconsin , USA"},{"name":"Endocrinology and Reproductive Physiology Program, University of Wisconsin-Madison , Madison, Wisconsin , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milo C","family":"Wiltbank","sequence":"additional","affiliation":[{"name":"Department of Animal and Dairy Sciences, University of Wisconsin-Madison , Madison, Wisconsin , USA"},{"name":"Endocrinology and Reproductive Physiology Program, University of Wisconsin-Madison , Madison, Wisconsin , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura L","family":"Hernandez","sequence":"additional","affiliation":[{"name":"Department of Animal and Dairy Sciences, University of Wisconsin-Madison , Madison, Wisconsin , USA"},{"name":"Endocrinology and Reproductive Physiology Program, University of Wisconsin-Madison , Madison, Wisconsin , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,4,25]]},"reference":[{"key":"2023071322545582500_ref1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2885.2008.00944.x","article-title":"Serotonin: a review","volume":"31","author":"Mohammad-Zadeh","year":"2008","journal-title":"J Vet Pharmacol Ther"},{"key":"2023071322545582500_ref2","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1210\/en.2016-1839","article-title":"The diverse metabolic roles of peripheral serotonin","volume":"158","author":"Martin","year":"2017","journal-title":"Endocrinology"},{"key":"2023071322545582500_ref3","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1182\/blood-2011-09-336933","article-title":"Transporters in human platelets: physiologic function and impact for pharmacotherapy","volume":"119","author":"Jedlitschky","year":"2012","journal-title":"Blood"},{"key":"2023071322545582500_ref4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1124\/mi.10.4.6","article-title":"Molecular mechanisms of SERT in platelets: regulation of plasma serotonin levels","volume":"10","author":"Mercado","year":"2010","journal-title":"Mol Interv"},{"key":"2023071322545582500_ref5","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1124\/pr.111.004697","article-title":"Serotonin and blood pressure regulation","volume":"64","author":"Watts","year":"2012","journal-title":"Pharmacol Rev"},{"key":"2023071322545582500_ref6","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1210\/er.2018-00283","article-title":"Emerging roles for serotonin in regulating metabolism: new implications for an ancient molecule","volume":"40","author":"Yabut","year":"2019","journal-title":"Endocr Rev"},{"key":"2023071322545582500_ref7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1161\/01.HYP.11.2.111","article-title":"Serotoninergic mechanisms in hypertension. Focus on the effects of ketanserin","volume":"11","author":"Vanhoutte","year":"1988","journal-title":"Hypertension"},{"key":"2023071322545582500_ref8","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1042\/CS20040364","article-title":"5-HT in systemic hypertension: foe, friend or fantasy?","volume":"108","author":"Watts","year":"2005","journal-title":"Clin Sci"},{"key":"2023071322545582500_ref9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11906-021-01155-4","article-title":"The serotonin-immune axis in preeclampsia","volume":"23","author":"Gumusoglu","year":"2021","journal-title":"Curr Hypertens Rep"},{"key":"2023071322545582500_ref10","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1093\/clinchem\/39.8.1675","article-title":"Platelet-poor plasma serotonin in normal and preeclamptic pregnancy","volume":"39","author":"Middelkoop","year":"1993","journal-title":"Clin Chem"},{"key":"2023071322545582500_ref11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0301-2115(00)00367-5","article-title":"Pathophysiology of preeclampsia and the role of serotonin","volume":"95","author":"Bolte","year":"2001","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2023071322545582500_ref12","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/npp.2016.166","article-title":"Impact of maternal serotonin transporter genotype on placental serotonin, fetal forebrain serotonin, and neurodevelopment","volume":"42","author":"Muller","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"2023071322545582500_ref13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nature09972","article-title":"A transient placental source of serotonin for the fetal forebrain","volume":"472","author":"Bonnin","year":"2011","journal-title":"Nature"},{"key":"2023071322545582500_ref14","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nn1896","article-title":"Serotonin modulates the response of embryonic thalamocortical axons to netrin-1","volume":"10","author":"Bonnin","year":"2007","journal-title":"Nat Neurosci"},{"key":"2023071322545582500_ref15","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.1523\/JNEUROSCI.2534-15.2016","article-title":"Maternal inflammation disrupts fetal neurodevelopment via increased placental output of serotonin to the fetal brain","volume":"36","author":"Goeden","year":"2016","journal-title":"J Neurosci"},{"key":"2023071322545582500_ref16","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13478","article-title":"Serotonin homeostasis in the materno-foetal interface at term: role of transporters (SERT\/SLC6A4 and OCT3\/SLC22A3) and monoamine oxidase A (MAO-A) in uptake and degradation of serotonin by human and rat term placenta","volume":"229","author":"Karahoda","year":"2020","journal-title":"Acta Physiol"},{"key":"2023071322545582500_ref17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.placenta.2019.05.012","article-title":"Disrupted placental serotonin synthetic pathway and increased placental serotonin: potential implications in the pathogenesis of human fetal growth restriction","volume":"84","author":"Ranzil","year":"2019","journal-title":"Placenta"},{"key":"2023071322545582500_ref18","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/978-1-4939-3014-2_12","volume-title":"Prenatal and Postnatal Determinants of Development","author":"Velasquez","year":"2016"},{"key":"2023071322545582500_ref19","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/biolre\/ioz204","article-title":"Placental serotonin signaling, pregnancy outcomes, and regulation of fetal brain development","volume":"102","author":"Rosenfeld","year":"2020","journal-title":"Biol Reprod"},{"key":"2023071322545582500_ref20","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1061317","article-title":"Serotonin system in the human placenta\u2013the knowns and unknowns","volume":"13","author":"Peri\u0107","year":"2022","journal-title":"Front Endocrinol"},{"key":"2023071322545582500_ref21","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2165\/00003495-198632060-00002","article-title":"Fluoxetine","volume":"32","author":"Benfield","year":"1986","journal-title":"Drugs"},{"key":"2023071322545582500_ref22","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-2493","article-title":"Prenatal antidepressant use and risk of adverse neonatal outcomes","volume":"146","author":"Bandoli","year":"2020","journal-title":"Pediatrics"},{"key":"2023071322545582500_ref23","doi-asserted-by":"crossref","first-page":"544.e541","DOI":"10.1016\/j.ajog.2007.01.033","article-title":"Increasing use of antidepressants in pregnancy","volume":"196","author":"Cooper","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"2023071322545582500_ref24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ajog.2012.02.009","article-title":"Antidepressant use during pregnancy: the benefit-risk ratio","volume":"207","author":"Koren","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"2023071322545582500_ref25","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1517\/14740338.2015.997708","article-title":"Risk-benefit balance assessment of SSRI antidepressant use during pregnancy and lactation based on best available evidence","volume":"14","author":"Weisskopf","year":"2015","journal-title":"Expert Opin Drug Saf"},{"key":"2023071322545582500_ref26","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1080\/14740338.2019.1658740","article-title":"Risk-benefit balance assessment of SSRI antidepressant use during pregnancy and lactation based on best available evidence\u2013an update","volume":"18","author":"Fischer Fumeaux","year":"2019","journal-title":"Expert Opin Drug Saf"},{"key":"2023071322545582500_ref27","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1017\/S003329170600835X","article-title":"To treat or not to treat: maternal depression, SSRI use in pregnancy and adverse neonatal effects","volume":"36","author":"Austin","year":"2006","journal-title":"Psychol Med"},{"key":"2023071322545582500_ref28","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nm.2173","article-title":"Serotonin regulates pancreatic beta cell mass during pregnancy","volume":"16","author":"Kim","year":"2010","journal-title":"Nat Med"},{"key":"2023071322545582500_ref29","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1210\/me.2014-1204","article-title":"Serotonin regulates calcium homeostasis in lactation by epigenetic activation of hedgehog signaling","volume":"28","author":"Laporta","year":"2014","journal-title":"Mol Endocrinol"},{"key":"2023071322545582500_ref30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00004714-200204000-00005","article-title":"Serotonin and fluoxetine levels in plasma and platelets after fluoxetine treatment in depressive patients","volume":"22","author":"Blardi","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"2023071322545582500_ref31","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1002\/jcp.25812","article-title":"Serotonin transporter protects the placental cells against apoptosis in caspase 3-independent pathway","volume":"232","author":"Hadden","year":"2017","journal-title":"J Cell Physiol"},{"key":"2023071322545582500_ref32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijdevneu.2004.07.022","article-title":"Behavioral and cellular consequences of increasing serotonergic activity during brain development: a role in autism?","volume":"23","author":"Whitaker-Azmitia","year":"2005","journal-title":"Int J Dev Neurosci"},{"key":"2023071322545582500_ref33","doi-asserted-by":"crossref","first-page":"574034","DOI":"10.3389\/fcell.2020.574034","article-title":"Dynamics of tryptophan metabolic pathways in human placenta and placental-derived cells: effect of gestation age and trophoblast differentiation","volume":"8","author":"Karahoda","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"2023071322545582500_ref34","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1073\/pnas.0606722104","article-title":"Maternal serotonin is crucial for murine embryonic development","volume":"104","author":"Cote","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"2023071322545582500_ref35","volume-title":"Int J Mol Sci","author":"Bakovic","year":"2021"},{"key":"2023071322545582500_ref36","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13081306","article-title":"Effect of selected antidepressants on placental homeostasis of serotonin: maternal and Fetal perspectives","volume-title":"Staud F","author":"Horackova","year":"2021"},{"key":"2023071322545582500_ref37","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1042\/CS20201050","article-title":"Inhibition of mechanistic target of rapamycin signaling decreases levels of O-GlcNAc transferase and increases serotonin release in the human placenta","volume":"134","author":"Kelly","year":"2020","journal-title":"Clin Sci"},{"key":"2023071322545582500_ref38","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1023\/A:1006934807375","article-title":"Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors","volume":"19","author":"DeVane","year":"1999","journal-title":"Cell Mol Neurobiol"},{"key":"2023071322545582500_ref39","doi-asserted-by":"crossref","first-page":"20120407","DOI":"10.1098\/rstb.2012.0407","article-title":"\u2018It's the way that you look at it\u2019\u2014a cognitive neuropsychological account of SSRI action in depression","volume":"368","author":"Harmer","year":"2013","journal-title":"Philos Trans R Soc B: Biol Sci"},{"key":"2023071322545582500_ref40","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3389\/fncel.2017.00305","article-title":"From serotonin to neuroplasticity: evolvement of theories for major depressive disorder","volume":"11","author":"Liu","year":"2017","journal-title":"Front Cell Neurosci"},{"key":"2023071322545582500_ref41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.phrs.2018.08.005","article-title":"Serotonin, hematopoiesis and stem cells","volume":"140","author":"Fouquet","year":"2019","journal-title":"Pharmacol Res"},{"key":"2023071322545582500_ref42","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1210\/en.2018-00279","article-title":"Peripartum fluoxetine reduces maternal trabecular bone after weaning and elevates mammary gland serotonin and PTHrP","volume":"159","author":"Weaver","year":"2018","journal-title":"Endocrinology"},{"key":"2023071322545582500_ref43","doi-asserted-by":"crossref","first-page":"e15204","DOI":"10.14814\/phy2.15204","article-title":"Peripartal treatment with low-dose sertraline accelerates mammary gland involution and has minimal effects on maternal and offspring bone","volume":"10","author":"Sheftel","year":"2022","journal-title":"Physiol Rep"},{"key":"2023071322545582500_ref44","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41372-020-0598-0","article-title":"Maternal use of selective serotonin reuptake inhibitors (SSRI) during pregnancy-neonatal outcomes in correlation with placental histopathology","volume":"40","author":"Levy","year":"2020","journal-title":"J Perinatol"},{"key":"2023071322545582500_ref45","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1210\/en.2017-03025","article-title":"Pathway of maternal serotonin to the human embryo and Fetus","volume":"159","author":"Kliman","year":"2018","journal-title":"Endocrinology"},{"key":"2023071322545582500_ref46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0233979","article-title":"Maternal stress and placental function; ex vivo placental perfusion studying cortisol, cortisone, tryptophan and serotonin","volume":"15","author":"Mathiesen","year":"2020","journal-title":"PLoS One"},{"key":"2023071322545582500_ref47","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0028-2243(93)90025-8","article-title":"Systemic and uterine vascular response to serotonin in third trimester pregnant ewes","volume":"51","author":"Lang","year":"1993","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2023071322545582500_ref48","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.phrs.2012.01.008","article-title":"Evaluation of organic cation transporter 3 (SLC22A3) inhibition as a potential mechanism of antidepressant action","volume":"65","author":"Zhu","year":"2012","journal-title":"Pharmacol Res"},{"key":"2023071322545582500_ref49","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s40262-014-0233-3","article-title":"Placental transfer of antidepressant medications: implications for postnatal adaptation syndrome","volume":"54","author":"Ewing","year":"2015","journal-title":"Clin Pharmacokinet"},{"key":"2023071322545582500_ref50","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1056\/NEJMoa066584","article-title":"Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects","volume":"356","author":"Alwan","year":"2007","journal-title":"N Engl J Med"},{"key":"2023071322545582500_ref51","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/acps.13120","article-title":"In utero exposure to antidepressant medication and neonatal and child outcomes: a systematic review","volume":"141","author":"Fitton","year":"2020","journal-title":"Acta Psychiatr Scand"},{"key":"2023071322545582500_ref52","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/toxics10010011","article-title":"Effect of low and high doses of two selective serotonin reuptake inhibitors on pregnancy outcomes and neonatal mortality","volume":"10","author":"Domingues","year":"2022","journal-title":"Toxics"},{"key":"2023071322545582500_ref53","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0163-7258(99)00048-0","article-title":"Pharmacokinetics of selective serotonin reuptake inhibitors","volume":"85","author":"Hiemke","year":"2000","journal-title":"Pharmacol Ther"},{"key":"2023071322545582500_ref54","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.2165\/00003088-200241150-00002","article-title":"Clinical pharmacokinetics of sertraline","volume":"41","author":"DeVane","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"2023071322545582500_ref55","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00007691-200104000-00008","article-title":"Serum concentrations of fluoxetine in the clinical treatment setting","volume":"23","author":"Lundmark","year":"2001","journal-title":"Ther Drug Monit"},{"key":"2023071322545582500_ref56","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1055\/s-0028-1103296","article-title":"Placental transfer of SSRI and SNRI antidepressants and effects on the neonate","volume":"42","author":"Rampono","year":"2009","journal-title":"Pharmacopsychiatry"},{"key":"2023071322545582500_ref57","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1192\/bjp.bp.107.037101","article-title":"Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: population-based study","volume":"192","author":"Oberlander","year":"2008","journal-title":"Br J Psychiatry"},{"key":"2023071322545582500_ref58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fncel.2013.00047","article-title":"Placental serotonin: implications for the developmental effects of SSRIs and maternal depression","volume":"7","author":"Velasquez","year":"2013","journal-title":"Front Cell Neurosci"},{"key":"2023071322545582500_ref59","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2010.05.008","article-title":"Impact of antenatal selective serotonin reuptake inhibitor exposure on pregnancy outcomes in mice","volume":"203","author":"Bauer","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"2023071322545582500_ref60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002782","article-title":"Modulation of serotonin transporter function during Fetal development causes dilated heart cardiomyopathy and lifelong Behavioral abnormalities","volume":"3","author":"Noorlander","year":"2008","journal-title":"PLoS One"},{"key":"2023071322545582500_ref61","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/bcpt.12072","article-title":"In utero and Lactational exposure to fluoxetine in Wistar rats: pregnancy outcomes and sexual development","volume":"113","author":"Muller","year":"2013","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2023071322545582500_ref62","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1152\/japplphysiol.00020.2022","article-title":"Prenatal fluoxetine has long-lasting, differential effects on respiratory control in male and female rats","volume":"133","author":"Biancardi","year":"2022","journal-title":"J Appl Physiol"},{"key":"2023071322545582500_ref63","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.955560","article-title":"Fluoxetine-induced perinatal morbidity in a sheep model","volume":"9","author":"Domingues","year":"2022","journal-title":"Front Med"},{"key":"2023071322545582500_ref64","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1203\/00006450-200204000-00007","article-title":"Effect of maternal fluoxetine administration on uterine blood flow, fetal blood gas status, and growth","volume":"51","author":"Morrison","year":"2002","journal-title":"Pediatr Res"},{"key":"2023071322545582500_ref65","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1071\/RD05030","article-title":"Fluoxetine during pregnancy: impact on fetal development","volume":"17","author":"Morrison","year":"2005","journal-title":"Reprod Fertil Dev"},{"key":"2023071322545582500_ref66","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0165-3806(01)00255-3","article-title":"Fetal behavioural state changes following maternal fluoxetine infusion in sheep","volume":"131","author":"Morrison","year":"2001","journal-title":"Dev Brain Res"},{"key":"2023071322545582500_ref67","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.aquatox.2009.04.011","article-title":"Inhibition of egg production in zebrafish by fluoxetine and municipal effluents: a mechanistic evaluation","volume":"95","author":"Lister","year":"2009","journal-title":"Aquat Toxicol"},{"key":"2023071322545582500_ref68","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cbpc.2017.08.003","article-title":"Endocrine disrupting effects of waterborne fluoxetine exposure on the reproductive axis of female goldfish, Carassius auratus","volume":"202","author":"Mennigen","year":"2017","journal-title":"Comp Biochem Physiol C Toxicol Pharmacol"},{"key":"2023071322545582500_ref69","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.848581","article-title":"Pregnancy complications and neonatal mortality in a serotonin transporter null mouse model: insight into the use of selective serotonin reuptake inhibitor during pregnancy","volume":"9","author":"Domingues","year":"2022","journal-title":"Front Med"},{"key":"2023071322545582500_ref70","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.placenta.2021.09.021","article-title":"Placental changes in the serotonin transporter (Slc6a4) knockout mouse suggest a role for serotonin in controlling nutrient acquisition","volume":"115","author":"Mao","year":"2021","journal-title":"Placenta"},{"key":"2023071322545582500_ref71","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s40262-020-00915-w","article-title":"Innovative approaches for pharmacology studies in pregnant and lactating women: a viewpoint and lessons from HIV","volume":"59","author":"Eke","year":"2020","journal-title":"Clin Pharmacokinet"},{"key":"2023071322545582500_ref72","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41576-019-0169-4","article-title":"Mechanisms of early placental development in mouse and humans","volume":"21","author":"Hemberger","year":"2020","journal-title":"Nat Rev Genet"},{"key":"2023071322545582500_ref73","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.placenta.2015.03.003","article-title":"Animal models of fetal growth restriction: considerations for translational medicine","volume":"36","author":"Swanson","year":"2015","journal-title":"Placenta"},{"key":"2023071322545582500_ref74","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1440-1681.2008.04975.x","article-title":"Sheep models of intrauterine growth restriction: Fetal adaptations and consequences","volume":"35","author":"Morrison","year":"2008","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2023071322545582500_ref75","volume-title":"Maternal Adaptations to Pregnancy. In: Knobil and Neill's Physiology of Reproduction","author":"Thornburg","year":"2015","edition":"Fourth"},{"key":"2023071322545582500_ref76","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1530\/JOE-16-0340","article-title":"Vascular adaptation in pregnancy and endothelial dysfunction in preeclampsia","volume":"232","author":"Boeldt","year":"2017","journal-title":"J Endocrinol"},{"key":"2023071322545582500_ref77","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.2527\/1995.7361839x","article-title":"Utero-placental vascular development and placental function","volume":"73","author":"Reynolds","year":"1995","journal-title":"J Anim Sci"},{"key":"2023071322545582500_ref78","doi-asserted-by":"crossref","first-page":"R245","DOI":"10.1152\/ajpregu.00108.2002","article-title":"Possible mechanisms underlying pregnancy-induced changes in uterine artery endothelial function","volume":"284","author":"Bird","year":"2003","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2023071322545582500_ref79","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/S0301-2115(03)00173-8","article-title":"Uterine blood flow\u2014a determinant of fetal growth","volume":"110","author":"Lang","year":"2003","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2023071322545582500_ref80","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0031-6989(85)90067-0","article-title":"Serotonin and vascular reactivity","volume":"17","author":"Van Nueten","year":"1985","journal-title":"Pharmacol Res Commun"},{"key":"2023071322545582500_ref81","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/0002-9378(67)90328-6","article-title":"Mechanism of inhibitory action of 5-hydroxytryptamine on placental function","volume":"99","author":"Honey","year":"1967","journal-title":"Am J Obstet Gynecol"},{"key":"2023071322545582500_ref82","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1095\/biolreprod28.4.830","article-title":"Serotonin-induced disruption of implantation in the rat: I. Serum progesterone, implantation site blood flow, and intrauterine pO2","volume":"28","author":"Mitchell","year":"1983","journal-title":"Biol Reprod"},{"key":"2023071322545582500_ref83","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1095\/biolreprod29.1.151","article-title":"Serotonin-induced disruption of implantation in the rat: II. Suppression of decidualization","volume":"29","author":"Mitchell","year":"1983","journal-title":"Biol Reprod"},{"key":"2023071322545582500_ref84","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1203\/PDR.0b013e31821ba11a","article-title":"Third trimester fetal heart rate and Doppler middle cerebral artery blood flow velocity characteristics during prenatal selective serotonin reuptake inhibitor exposure","volume":"70","author":"Rurak","year":"2011","journal-title":"Pediatr Res"},{"key":"2023071322545582500_ref85","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.mehy.2011.05.023","article-title":"SSRIs and placental dysfunction","volume":"2","author":"Banga","year":"2011","journal-title":"Med Hypotheses"},{"key":"2023071322545582500_ref86","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/JCP.0000000000000964","article-title":"The relationship between pregnancy exposure to antidepressant and atypical antipsychotic medications and placental weight and birth weight ratio: a retrospective cohort study","volume":"38","author":"Frayne","year":"2018","journal-title":"J Clin Psychopharmacol"},{"key":"2023071322545582500_ref87","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/pr.2017.156","article-title":"Neonatal adaptation following intrauterine antidepressant exposure: assessment, drug assay levels, and infant development outcomes","volume":"82","author":"Galbally","year":"2017","journal-title":"Pediatr Res"},{"key":"2023071322545582500_ref88","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1080\/14767058.2016.1209184","article-title":"Placental and fetal effects of antenatal exposure to antidepressants or untreated maternal depression","volume":"30","author":"Gentile","year":"2017","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2023071322545582500_ref89","doi-asserted-by":"crossref","first-page":"e0116459","DOI":"10.1371\/journal.pone.0116459","article-title":"The effect of antenatal depression and selective serotonin reuptake inhibitor treatment on nerve growth factor signaling in human placenta","volume":"10","author":"Kaihola","year":"2015","journal-title":"PloS One"},{"key":"2023071322545582500_ref90","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3389\/fncel.2014.00465","article-title":"The effects of antenatal depression and antidepressant treatment on placental gene expression","volume":"8","author":"Olivier","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"2023071322545582500_ref91","article-title":"Balanced levels of nerve growth factor are required for normal pregnancy progression","volume-title":"Reproduction","author":"Frank"},{"key":"2023071322545582500_ref92","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000087962","article-title":"Nerve growth factor in reproductive biology: link between the immune, endocrine and nervous system?","volume":"89","author":"Tometten","year":"2005","journal-title":"Immunol Pregnancy"},{"key":"2023071322545582500_ref93","doi-asserted-by":"crossref","DOI":"10.1016\/j.placenta.2022.09.013","article-title":"Altered activities of CYP1A1 and CYP19A1 enzymes in women using SSRI medication during pregnancy","volume":"129","author":"Sahlman","year":"2022","journal-title":"Placenta"},{"key":"2023071322545582500_ref94","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.reprotox.2012.04.001","article-title":"In vivo and in vitro estrogenic activity of the antidepressant fluoxetine","volume":"34","author":"Muller","year":"2012","journal-title":"Reprod Toxicol"},{"key":"2023071322545582500_ref95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tiv.2017.02.001","article-title":"The six most widely used selective serotonin reuptake inhibitors decrease androgens and increase estrogens in the H295R cell line","volume":"41","author":"Hansen","year":"2017","journal-title":"Toxicol In Vitro"},{"key":"2023071322545582500_ref96","first-page":"420","article-title":"Fluoxetine modulates sex steroid levels in vitro","volume":"90","author":"Lupu","year":"2017","journal-title":"Clujul Med"},{"key":"2023071322545582500_ref97","doi-asserted-by":"crossref","first-page":"111783","DOI":"10.1016\/j.mce.2022.111783","article-title":"The antidepressant fluoxetine (Prozac\u00ae) modulates estrogen signaling in the uterus and alters estrous cycles in mice","volume":"559","author":"Domingues","year":"2023","journal-title":"Mol Cell Endocrinol"},{"key":"2023071322545582500_ref98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-022-26071-8","article-title":"Profiling placental DNA methylation associated with maternal SSRI treatment during pregnancy","volume":"12","author":"Inkster","year":"2022","journal-title":"Sci Rep"},{"key":"2023071322545582500_ref99","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/jp.2013.176","article-title":"Placental pathology, first-trimester biomarkers and adverse pregnancy outcomes","volume":"34","author":"Odibo","year":"2014","journal-title":"J Perinatol"},{"key":"2023071322545582500_ref100","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2018.00570","article-title":"Regulation of placental development and its impact on fetal growth-new insights from mouse models","volume":"9","author":"Woods","year":"2018","journal-title":"Front Endocrinol"},{"key":"2023071322545582500_ref101","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/ddr.430080121","article-title":"Protective activity of ketanserin against serotonin-induced embryotoxicity and teratogenicity in rats","volume":"8","author":"Van Cauteren","year":"1986","journal-title":"Drug Dev Res"},{"key":"2023071322545582500_ref102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12884-019-2586-y","article-title":"The effect of antenatal depression and antidepressant treatment on placental tissue: a protein-validated gene expression study","volume":"19","author":"Edvinsson","year":"2019","journal-title":"BMC Pregnancy Childbirth"},{"key":"2023071322545582500_ref103","doi-asserted-by":"crossref","first-page":"100073","DOI":"10.1016\/j.crtox.2022.100073","article-title":"Antidepressants induce toxicity in human placental BeWo cells","volume":"3","author":"Nabekura","year":"2022","journal-title":"Curr Res Toxicol"},{"key":"2023071322545582500_ref104","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.placenta.2018.10.007","article-title":"Effects of selective serotonin-reuptake inhibitors (SSRIs) in JEG-3 and HIPEC cell models of the extravillous trophoblast","volume":"72","author":"Clabault","year":"2018","journal-title":"Placenta"},{"key":"2023071322545582500_ref105","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.taap.2018.04.018","article-title":"Effects of selective serotonin-reuptake inhibitors (SSRIs) on human villous trophoblasts syncytialization","volume":"349","author":"Clabault","year":"2018","journal-title":"Toxicol Appl Pharmacol"},{"key":"2023071322545582500_ref106","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1053\/j.semperi.2008.08.001","article-title":"Fetal and neonatal effects of maternal drug treatment for depression","volume":"32","author":"Belik","year":"2008","journal-title":"Semin Perinatol"},{"key":"2023071322545582500_ref107","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2165\/11634190-000000000-00000","article-title":"Early morbidity and mortality following in utero exposure to selective serotonin reuptake inhibitors","volume":"26","author":"Colvin","year":"2012","journal-title":"CNS Drugs"},{"key":"2023071322545582500_ref108","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1177\/000992280104001207","article-title":"Fluoxetine toxicity in a breastfed infant","volume":"40","author":"Hale","year":"2001","journal-title":"Clin Pediatr"},{"key":"2023071322545582500_ref109","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1080\/14767050802266899","article-title":"Prolonged neonatal complications after in utero exposure to fluoxetine","volume":"21","author":"Alehan","year":"2008","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2023071322545582500_ref110","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1001\/archpsyc.60.7.720","article-title":"Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations","volume":"60","author":"Laine","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"2023071322545582500_ref111","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/j.ajog.2005.05.012","article-title":"Citalopram use in pregnancy: prospective comparative evaluation of pregnancy and fetal outcome","volume":"193","author":"Sivojelezova","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"2023071322545582500_ref112","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/bcp.12849","article-title":"The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta-analysis","volume":"81","author":"Berard","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"2023071322545582500_ref113","doi-asserted-by":"crossref","first-page":"e013372","DOI":"10.1136\/bmjopen-2016-013372","article-title":"Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec pregnancy cohort","volume":"7","author":"B\u00e9rard","year":"2017","journal-title":"BMJ Open"},{"key":"2023071322545582500_ref114","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1203\/PDR.0b013e318193594a","article-title":"Effect of exposure to selective serotonin reuptake inhibitors in utero on fetal growth: potential role for the IGF-I and HPA axes","volume":"65","author":"Davidson","year":"2009","journal-title":"Pediatr Res"},{"key":"2023071322545582500_ref115","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/archgenpsychiatry.2011.2333","article-title":"Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes","volume":"69","author":"El Marroun","year":"2012","journal-title":"Arch Gen Psychiatry"},{"key":"2023071322545582500_ref116","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1017\/S2040174411000808","article-title":"Prenatal exposure to selective serotonin reuptake inhibitors and risk of childhood overweight","volume":"3","author":"Grzeskowiak","year":"2012","journal-title":"J Dev Orig Health Dis"},{"key":"2023071322545582500_ref117","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-0181","article-title":"Neonatal morbidity after maternal use of antidepressant drugs during pregnancy","volume":"138","author":"Norby","year":"2016","journal-title":"Pediatrics"},{"key":"2023071322545582500_ref118","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ijdevneu.2007.06.003","article-title":"Developmental effects of SSRIs: lessons learned from animal studies","volume":"25","author":"Borue","year":"2007","journal-title":"Int J Dev Neurosci"},{"key":"2023071322545582500_ref119","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1056\/NEJMoa052744","article-title":"Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn","volume":"354","author":"Chambers","year":"2006","journal-title":"N Engl J Med"},{"key":"2023071322545582500_ref120","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1089\/jwh.2018.7319","article-title":"Selective serotonin reuptake inhibitors and persistent pulmonary hypertension of the newborn: an updated meta-analysis","volume":"28","author":"Ng","year":"2019","journal-title":"J Womens Health"},{"key":"2023071322545582500_ref121","first-page":"bcr2015209418","article-title":"Serotonin syndrome in a breast-fed neonate","volume":"2015","author":"Morris","year":"2015","journal-title":"Case Rep"},{"key":"2023071322545582500_ref122","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-2250","article-title":"Why the maternal medication list matters: neonatal toxicity from combined serotonergic exposures","volume":"147","author":"Brajcich","year":"2021","journal-title":"Pediatrics"},{"key":"2023071322545582500_ref123","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1177\/0269881105056554","article-title":"Neonatal symptoms following maternal paroxetine treatment: serotonin toxicity or paroxetine discontinuation syndrome?","volume":"19","author":"Haddad","year":"2005","journal-title":"J Psychopharmacol"},{"key":"2023071322545582500_ref124","doi-asserted-by":"crossref","first-page":"F147","DOI":"10.1136\/fn.85.2.F145g","article-title":"Neonatal paroxetine withdrawal syndrome or actually serotonin syndrome?","volume":"85","author":"Isbister","year":"2001","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"2023071322545582500_ref125","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJM199610033351402","article-title":"Birth outcomes in pregnant women taking fluoxetine","volume":"335","author":"Chambers","year":"1996","journal-title":"N Engl J Med"},{"key":"2023071322545582500_ref126","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.genhosppsych.2013.08.002","article-title":"A meta-analysis of the relationship between antidepressant use in pregnancy and the risk of preterm birth and low birth weight","volume":"36","author":"Huang","year":"2014","journal-title":"Gen Hosp Psychiatry"},{"key":"2023071322545582500_ref127","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.ajog.2006.02.019","article-title":"Selective serotonin reuptake inhibitors and adverse pregnancy outcomes","volume":"194","author":"Wen","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"2023071322545582500_ref128","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1001\/archpsyc.63.8.898","article-title":"Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data","volume":"63","author":"Oberlander","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"2023071322545582500_ref129","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jad.2018.08.061","article-title":"A meta-analysis of selective serotonin reuptake inhibitors (SSRIs) use during prenatal depression and risk of low birth weight and small for gestational age","volume":"241","author":"Zhao","year":"2018","journal-title":"J Affect Disord"},{"key":"2023071322545582500_ref130","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/JCP.0000000000001410","article-title":"Association of antidepressant continuation in pregnancy and infant birth weight","volume":"41","author":"Wartko","year":"2021","journal-title":"J Clin Psychopharmacol"},{"key":"2023071322545582500_ref131","doi-asserted-by":"crossref","first-page":"579.e571","DOI":"10.1016\/j.ajog.2009.06.061","article-title":"Risk of preterm delivery and other adverse perinatal outcomes in relation to maternal use of psychotropic medications during pregnancy","volume":"201","author":"Calderon-Margalit","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"2023071322545582500_ref132","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.00659","article-title":"Antidepressant use in depressed women during pregnancy and the risk of preterm birth: a systematic review and meta-analysis of 23 cohort studies","volume":"11","author":"Chang","year":"2020","journal-title":"Front Pharmacol"},{"key":"2023071322545582500_ref133","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1542\/peds.113.2.368","article-title":"Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior","volume":"113","author":"Zeskind","year":"2004","journal-title":"Pediatrics"},{"key":"2023071322545582500_ref134","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s11920-022-01372-x","article-title":"Selective serotonin reuptake inhibitors (SSRIs) in pregnancy: an updated review on risks to mother, fetus, and child","volume":"24","author":"Lebin","year":"2022","journal-title":"Curr Psychiatry Rep"},{"key":"2023071322545582500_ref135","doi-asserted-by":"crossref","first-page":"49.e1","DOI":"10.1016\/j.ajog.2012.04.028","article-title":"Maternal antidepressant use and adverse outcomes: a cohort study of 228,876 pregnancies","volume":"207","author":"Hayes","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"2023071322545582500_ref136","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/ije\/dyv351","article-title":"Selective serotonin re-uptake inhibitor use during pregnancy: association with offspring birth size and gestational age","volume":"45","author":"Viktorin","year":"2016","journal-title":"Int J Epidemiol"},{"key":"2023071322545582500_ref137","first-page":"490","article-title":"Intrauterine growth restriction","volume":"99","author":"Resnik","year":"2002","journal-title":"Obstet Gynecol"},{"key":"2023071322545582500_ref138","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1365-2214.2001.00203.x","article-title":"The long-term costs of preterm birth and low birth weight: results of a systematic review","volume":"27","author":"Petrou","year":"2001","journal-title":"Child Care Health Dev"},{"key":"2023071322545582500_ref139","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1742-7843.2007.00186.x","article-title":"Developmental origins of health and disease: new insights","volume":"102","author":"Hanson","year":"2008","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2023071322545582500_ref140","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1590\/S0100-879X1999000100014","article-title":"Postnatal development of rats exposed to fluoxetine or venlafaxine during the third week of pregnancy","volume":"32","author":"Da-Silva","year":"1999","journal-title":"Braz J Med Biol Res"},{"key":"2023071322545582500_ref141","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/bdr2.1660","article-title":"The teratogenic effects of sertraline in mice","volume":"112","author":"Cabrera","year":"2020","journal-title":"Birth Defects Res"},{"key":"2023071322545582500_ref142","first-page":"922","article-title":"Mouse models of preterm birth: suggested assessment and reporting guidelines","volume":"99","author":"McCarthy","year":"2018","journal-title":"Biol Reprod"},{"key":"2023071322545582500_ref143","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.reprotox.2010.10.003","article-title":"Developmental exposure to TCDD reduces fertility and negatively affects pregnancy outcomes across multiple generations","volume":"31","author":"Bruner-Tran","year":"2011","journal-title":"Reprod Toxicol"},{"key":"2023071322545582500_ref144","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/0002-9378(66)90774-5","article-title":"Growth of the human fetus: I. Normal growth and its variation","volume":"94","author":"Gruenwald","year":"1966","journal-title":"Am J Obstet Gynecol"},{"key":"2023071322545582500_ref145","volume":"226"},{"key":"2023071322545582500_ref146","volume":"23"},{"key":"2023071322545582500_ref147","volume":"79"},{"key":"2023071322545582500_ref148","volume":"12"},{"key":"2023071322545582500_ref149","volume":"181"},{"key":"2023071322545582500_ref150","volume":"93"}],"container-title":["Biology of Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/biolreprod\/advance-article-pdf\/doi\/10.1093\/biolre\/ioad046\/50277147\/ioad046.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biolreprod\/article-pdf\/109\/1\/17\/50853324\/ioad046.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biolreprod\/article-pdf\/109\/1\/17\/50853324\/ioad046.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T18:57:43Z","timestamp":1689274663000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/biolreprod\/article\/109\/1\/17\/7142611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,25]]},"references-count":150,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,4,25]]},"published-print":{"date-parts":[[2023,7,11]]}},"URL":"https:\/\/doi.org\/10.1093\/biolre\/ioad046","relation":{},"ISSN":["0006-3363","1529-7268"],"issn-type":[{"value":"0006-3363","type":"print"},{"value":"1529-7268","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,7]]},"published":{"date-parts":[[2023,4,25]]}}}